Showing results (501-510 of 1,319) with videos related to
Sort By:
Pageof 132
Mutation Research|February 1, 1992
Micronucleus tests on N-ethyl-N-nitrosourea with mouse peripheral blood reticulocytes using acridine orange-coated slidesS Hitotsumachi, Y Kimura, M Katoh, et al.Journal of Gastroenterology and Hepatology|August 26, 1998
Case report: a long-term survivor of jejunal leiomyosarcoma with liver metastasis: effective transcathetel arterial embolization for hepatic metastatic fociT Hara, I Wada, S Kajihara, et al.FEBS Letters|April 6, 1992
Direct expression in Escherichia coli and characterization of bovine adrenodoxins with modified amino-terminal regionsY Sagara, T Hara, Y Ariyasu, et al.The Journal of Biological Chemistry|December 5, 1998
Mammalian cell mutants resistant to a sphingomyelin-directed cytolysin. Genetic and biochemical evidence for complex formation of the LCB1 protein with the LCB2 protein for serine palmitoyltransferaseK Hanada, T Hara, M Fukasawa, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|December 5, 1998
[A case report of cavernous hemangioma of the left atrial epicardium]T Hara, T Ushijima, H Takemura, et al.Immunobiology|September 1, 1991
Enhancement of lymphocyte-mediated K562 cytotoxicity by antibodies against complement membrane cofactor protein (CD46) and decay-accelerating factor (CD55)T Seya, A Kojima, T Hara, et al.American Journal of Dentistry|October 1, 2013
In vitro caries lesion rehardening and enamel fluoride uptake from fluoride varnishes as a function of application modeFrank Lippert, Anderson T Hara, Esperanza Angeles Martinez-Mier, et al.Molecular Immunology|January 1, 1995
Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathwayT Masaki, M Matsumoto, T Hara, et al.The Japanese Journal of Antibiotics|August 1, 1985
[The duration of antibacterial treatment following transurethral prostatectomy]K Fujita, T Sayama, S Abe, et al.Beneficial Microbes|April 28, 2016
Infant formula with galacto-oligosaccharides (OM55N) stimulates the growth of indigenous bifidobacteria in healthy term infantsT Matsuki, S Tajima, T Hara, et al.Pageof 132